Education
About Us
Working with TipRanks
Follow Us
Adaptimmune Therapeutics (ADAP)
NASDAQ:ADAP
Adaptimmune Therapeutics (ADAP) Ownership Overview
37.90% Insiders
0.16% Mutual Funds
39.11% Other Institutional Investors
0.16% ETFs
22.66% Public Companies and
Individual Investors
The ownership structure of Adaptimmune Therapeutics (ADAP) stock is a mix of institutional, retail, and individual investors. Approximately 39.44% of the company’s stock is owned by Institutional Investors, 37.90% is owned by Insiders, and 22.66% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Aug 29, 2025 | xxxxxxxxxxxxx | $2070 | |
Aug 19, 2025 | xxxxxxxxxxxxx | $195000 | |
Jul 30, 2025 | xxxxxxxxxxxxx | $6744571 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 100,371,882 | Insider | 37.87% | 5,921,941 | |
| 37,681,515 | Institution | 14.22% | 2,223,209 | |
| 435,717 | Institution | 0.16% | 25,707 | |
| 246,744 | Institution | 0.09% | 14,558 | |
| 99,822 | Institution | 0.04% | 5,889 | |
| 87,274 | Institution | 0.03% | 5,149 | |
| 67,032 | Institution | 0.03% | 3,955 | |
| 44,327 | Insider | 0.02% | 2,615 | |
| 18,421 | Insider | <0.01% | 1,087 | |
| 16,257 | Institution | <0.01% | 959 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 246,744 | Institution | 0.09% | 14,558 | |
| 99,822 | Institution | 0.04% | 5,889 | |
| 67,032 | Institution | 0.03% | 3,955 | |
| 16,257 | Institution | <0.01% | 959 | |
| 6,385 | Institution | <0.01% | 377 | |
| 554 | Institution | <0.01% | 33 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 291,801 | Institution | 0.11% | 21,272 | |
| 143,916 | Institution | 0.05% | 10,491 |
FAQ
Who Owns Adaptimmune Therapeutics (ADAP)?
According to the latest TipRanks data, approximately 39.11% of the company's stock is held by institutional investors, 37.90% is held by insiders, and 22.66% is held by retail investors.
What percentage of Adaptimmune Therapeutics (ADAP) stock is held by institutional investors?
According to the latest TipRanks data, approximately 39.11% of Adaptimmune Therapeutics (ADAP) stock is held by institutional investors.
What percentage of Adaptimmune Therapeutics (ADAP) stock is held by retail investors?
According to the latest TipRanks data, approximately 22.66% of Adaptimmune Therapeutics (ADAP) stock is held by retail investors.
Who owns the most shares of Adaptimmune Therapeutics (ADAP)?
Ecor1 Capital, Llc owns the most shares of Adaptimmune Therapeutics (ADAP).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.